Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DIVIS LABORATORIES vs WOCKHARDT - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DIVIS LABORATORIES WOCKHARDT DIVIS LABORATORIES/
WOCKHARDT
 
P/E (TTM) x 66.4 -15.8 - View Chart
P/BV x 7.2 2.5 285.4% View Chart
Dividend Yield % 0.9 0.0 -  

Financials

 DIVIS LABORATORIES   WOCKHARDT
EQUITY SHARE DATA
    DIVIS LABORATORIES
Mar-23
WOCKHARDT
Mar-23
DIVIS LABORATORIES/
WOCKHARDT
5-Yr Chart
Click to enlarge
High Rs4,641316 1,471.0%   
Low Rs2,730145 1,878.2%   
Sales per share (Unadj.) Rs292.6184.0 159.0%  
Earnings per share (Unadj.) Rs68.7-43.1 -159.4%  
Cash flow per share (Unadj.) Rs81.6-25.7 -317.8%  
Dividends per share (Unadj.) Rs30.000-  
Avg Dividend yield %0.80-  
Book value per share (Unadj.) Rs480.9231.7 207.6%  
Shares outstanding (eoy) m265.47144.09 184.2%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x12.61.3 1,005.7%   
Avg P/E ratio x53.7-5.3 -1,003.6%  
P/CF ratio (eoy) x45.2-9.0 -503.2%  
Price / Book Value ratio x7.71.0 770.4%  
Dividend payout %43.70-   
Avg Mkt Cap Rs m978,37833,202 2,946.8%   
No. of employees `000NANA-   
Total wages/salary Rs m9,7506,370 153.1%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m77,67526,510 293.0%  
Other income Rs m3,4471,220 282.5%   
Total revenues Rs m81,12227,730 292.5%   
Gross profit Rs m23,691-1,930 -1,227.5%  
Depreciation Rs m3,4322,510 136.7%   
Interest Rs m203,020 0.6%   
Profit before tax Rs m23,686-6,240 -379.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m5,453-30 -18,175.0%   
Profit after tax Rs m18,234-6,210 -293.6%  
Gross profit margin %30.5-7.3 -418.9%  
Effective tax rate %23.00.5 4,788.1%   
Net profit margin %23.5-23.4 -100.2%  
BALANCE SHEET DATA
Current assets Rs m97,43719,140 509.1%   
Current liabilities Rs m15,33134,350 44.6%   
Net working cap to sales %105.7-57.4 -184.2%  
Current ratio x6.40.6 1,140.6%  
Inventory Days Days839 21.3%  
Debtors Days Days84211 7,676.0%  
Net fixed assets Rs m51,12848,670 105.1%   
Share capital Rs m531720 73.7%   
"Free" reserves Rs m127,14032,660 389.3%   
Net worth Rs m127,67133,380 382.5%   
Long term debt Rs m02,240 0.0%   
Total assets Rs m148,56570,750 210.0%  
Interest coverage x1,209.5-1.1 -113,436.1%   
Debt to equity ratio x00.1 0.0%  
Sales to assets ratio x0.50.4 139.5%   
Return on assets %12.3-4.5 -272.5%  
Return on equity %14.3-18.6 -76.8%  
Return on capital %18.6-9.0 -205.4%  
Exports to sales %85.70-   
Imports to sales %19.83.5 570.5%   
Exports (fob) Rs m66,537NA-   
Imports (cif) Rs m15,378920 1,671.5%   
Fx inflow Rs m66,537730 9,114.6%   
Fx outflow Rs m15,715920 1,708.1%   
Net fx Rs m50,822-190 -26,748.5%   
CASH FLOW
From Operations Rs m24,5971,530 1,607.7%  
From Investments Rs m-27,076-1,250 2,166.1%  
From Financial Activity Rs m-7,972-3,150 253.1%  
Net Cashflow Rs m-10,451-2,800 373.2%  

Share Holding

Indian Promoters % 51.9 54.9 94.5%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 36.7 4.5 820.1%  
FIIs % 14.9 4.2 356.1%  
ADR/GDR % 0.0 0.0 -  
Free float % 48.1 45.1 106.7%  
Shareholders   354,482 161,813 219.1%  
Pledged promoter(s) holding % 0.0 74.5 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DIVIS LABORATORIES With:   SUN PHARMA    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    MANKIND PHARMA    


More on Divis Laboratories vs Wockhardt

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Divis Laboratories vs Wockhardt Share Price Performance

Period Divis Laboratories Wockhardt S&P BSE HEALTHCARE
1-Day 2.77% 4.99% 1.41%
1-Month -1.54% 0.15% -0.53%
1-Year 23.27% 290.07% 62.18%
3-Year CAGR -1.17% 13.79% 18.25%
5-Year CAGR 15.91% 7.92% 19.84%

* Compound Annual Growth Rate

Here are more details on the Divis Laboratories share price and the Wockhardt share price.

Moving on to shareholding structures...

The promoters of Divis Laboratories hold a 51.9% stake in the company. In case of Wockhardt the stake stands at 54.9%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Divis Laboratories and the shareholding pattern of Wockhardt.

Finally, a word on dividends...

In the most recent financial year, Divis Laboratories paid a dividend of Rs 30.0 per share. This amounted to a Dividend Payout ratio of 43.7%.

Wockhardt paid Rs 0.0, and its dividend payout ratio stood at -0.0%.

You may visit here to review the dividend history of Divis Laboratories, and the dividend history of Wockhardt.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 550 Points| Nifty Tops 22,250 | Power Stocks Shine Sensex Today Rallies 550 Points| Nifty Tops 22,250 | Power Stocks Shine(10:30 am)

Asian markets traded lower, while the US stock indices ended higher overnight with the S&P 500 hitting a record closing high ahead of key economic data.